First Quadrant’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-32,700
Closed -$954K 544
2021
Q4
$954K Hold
32,700
0.1% 171
2021
Q3
$705K Hold
32,700
0.08% 208
2021
Q2
$839K Sell
32,700
-2,369
-7% -$50.6K 0.1% 190
2021
Q1
$639K Buy
35,069
+33,278
+1,858% +$553K 0.07% 224
2020
Q4
$21K Buy
+1,791
New +$16.4K ﹤0.01% 521

Other funds holding CDMO

First Quadrant's CDMO Position: Q1 2022 in Review

First Quadrant sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2022, closing a stake of 32,700 shares — an estimated $954K sold.

First Quadrant first reported a position in CDMO in Q4 2020 and held it in 5 quarters. The position peaked at $954K in Q4 2021. 193 funds tracked by Wall St. Rank hold CDMO as of Q1 2022.

  • First Quadrant reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • First Quadrant sold 32,700 Avid Bioservices, Inc. Common Stock shares in Q1 2022, an estimated $954K.
  • First Quadrant first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • First Quadrant's Avid Bioservices, Inc. Common Stock position peaked at $954K in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.